Company · CIK 0001412486 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Cocrystal Pharma, Inc. · COCP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 PForm 4 → | Aug 6, 5:11 pm EDT | Phillip Md Et Al FrostDirector, 10% Owner | 10,000 | $0.9816 | $9,816 | 1,993,551 | +0.50% | |
| Aug 3, 2026 PForm 4 → | Aug 5, 4:10 pm EDT | Phillip Md Et Al FrostDirector, 10% Owner | 75,000 | $0.9412 | $70,590 | 1,983,551 | +3.93% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 AForm 4 → | Jun 3, 4:10 pm EDT | James SapirsteinChief Executive Officer | 235,000 | — | — | 235,000 | — |